Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 19.09.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 24.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Office |
| 19.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers |
| 27.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers |
| 12.01.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Offi |
| 14.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Offi |
| 23.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers |
Stammdaten
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Unternehmen & Branche
| Name | Microbot Medical Inc. |
|---|---|
| Ticker | MBOT |
| CIK | 0000883975 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Instruments & Supplies |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 95,6 Mio. USD |
| Beta | 1,19 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -13,142,000 | -0.29 | 81,544,000 | 77,554,000 | |
| 2025-09-30 | 10-Q | -3,577,000 | -0.07 | 81,760,000 | 78,224,000 | |
| 2025-06-30 | 10-Q | -3,500,000 | -0.10 | 33,131,000 | 30,357,000 | |
| 2025-03-31 | 10-Q | -2,601,000 | -0.08 | 30,892,000 | 28,951,000 | |
| 2024-12-31 | 10-K | -11,443,000 | -0.73 | 6,031,000 | 3,530,000 | |
| 2024-09-30 | 10-Q | -3,215,000 | -0.20 | 5,208,000 | 3,808,000 | |
| 2024-06-30 | 10-Q | -2,465,000 | -0.17 | 7,434,000 | 6,055,000 | |
| 2024-03-31 | 10-Q | -2,371,000 | -0.17 | 7,367,000 | 6,167,000 | |
| 2023-12-31 | 10-K | -10,740,000 | -1.05 | 8,327,000 | 4,501,000 | |
| 2023-09-30 | 10-Q | -2,446,000 | -0.21 | 8,888,000 | 7,358,000 | |
| 2023-06-30 | 10-Q | -2,287,000 | -0.25 | 10,884,000 | 9,468,000 | |
| 2023-03-31 | 10-Q | -2,853,000 | -0.36 | 6,208,000 | 4,848,000 | |
| 2022-12-31 | 10-K | -13,168,000 | -1.81 | 9,537,000 | 7,289,000 | |
| 2022-09-30 | 10-Q | -3,468,000 | -0.49 | 7,409,000 | 5,533,000 | |
| 2022-06-30 | 10-Q | -3,513,000 | -0.49 | 10,542,000 | 8,540,000 | |
| 2022-03-31 | 10-Q | -3,189,000 | 13,682,000 | 11,621,000 | ||
| 2021-12-31 | 10-K | -11,313,000 | 16,767,000 | 14,381,000 | ||
| 2021-09-30 | 10-Q | -2,555,000 | 19,701,000 | 17,870,000 | ||
| 2021-06-30 | 10-Q | -2,511,000 | 21,865,000 | 20,118,000 | ||
| 2021-03-31 | 10-Q | -2,388,000 | 24,170,000 | 22,330,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.